Anqi Zhang is a Postdoctoral Associate in the School of Pharmacy and Pharmaceutical Sciences at ßÙßÇÂþ», working with Prof. Nathan Tumey. Her research focuses on developing targeted immunotherapies for cancer and immune-driven disorders, with an emphasis on immune-modulating antibody conjugates designed for both immune-stimulating and immune-suppressive applications. Dr. Zhang earned her Ph.D. in Chemistry from ßÙßÇÂþ» under the mentorship of Prof. Ming An, where she developed ultra-pH-sensitive prodrugs of doxorubicin for tumor-selective delivery and collaborated with Prof. Wei Qiang on mechanistic studies of pH-low insertion peptides. She then completed a postdoctoral fellowship at Northwestern University with Prof. SonBinh Nguyen, investigating nanoparticle delivery of monobenzone analogs for melanoma therapy. Following this, she pursued postdoctoral research at Purdue University with Prof. Philip S. Low, focusing on folate-targeted immunotherapies and small-molecule STING agonists for cancer. In addition to her research, Dr. Zhang is committed to teaching and mentoring. She has taught in both the Department of Chemistry and the School of Pharmacy at ßÙßÇÂþ» and has mentored more than 20 undergraduate and graduate students across ßÙßÇÂþ», Northwestern, and Purdue. At ßÙßÇÂþ», she has taught Chemistry Laboratories and Organic Chemistry II, as well as Chemical Technology for Drug Discovery and Drug Delivery and the medicinal chemistry portion of Integrated Pharmacotherapy VIII in the pharmacy curriculum.
Anqi Zhang
Postdoctoral Associate
School of Pharmacy and Pharmaceutical Sciences
Background
Research Interests